Planet Biotechnology, Inc.
Publicly observedHayward, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Hayward | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Planet Biotechnology, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | KTJKPBE2H5H3 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Aug 2024Publicly observed
NIH SBIR/STTR award: Bispecific antibody for topical administration to prevent gonorrhea
USD 299,999.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant17 Jul 2024Publicly observed
NIH SBIR/STTR award: Developing a Potent Broad-Spectrum Prophylactic for Tickborne Disease
USD 300,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant10 Jul 2024Publicly observed
NIH SBIR/STTR award: Factor H-Fc Fusion as a Pre-Exposure Prophylactic for Rickettsia Infections
USD 295,353.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant4 Apr 2024Publicly observed
NIH SBIR/STTR award: A broad spectrum anti-gonorrhea immunotherapeutic
USD 296,920.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.